Clinical Trial Update: GRX With ReMOTE: First in Human in India [NA]

View source ↗

Summary

First-in-human clinical trial update for GRX with ReMOTE in India; study completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Percutaneous Coronary Intervention

Drugs mentioned

• GRX with ReMOTE

Snippet

Sponsor: Corindus Inc. | Conditions: Percutaneous Coronary Intervention | NA | Status: COMPLETED | Results posted: 2020-01-31